Clal Biotechnology (Israel) Profile

ILS 10.4  3.2%

Clal Biotechnology Summary

Clal Biotechnology Industries Ltd (CBI) is traded on Tel Aviv Stock Exchange in Israel. It is located in Azrieli Center and employs 14 people. The company currently falls under 'Small-Cap' category with current market capitalization of 494.85 M. Clal Biotechnology Industries Ltd has 156.45 M outstanding shares. CLAL BIOTECH has accumulated about 140.09 M in cash with (79.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91.
Check Clal Biotechnology Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 314.5HorizonTargetOdds Above 314.5
11.52%30 days 314.50 88.31%
Based on normal probability distribution, the odds of Clal Biotechnology to move above current price in 30 days from now is about 88.31% (This Clal Biotechnology Industries Ltd probability density function shows the probability of Clal Biotechnology Stock to fall within a particular range of prices over 30 days) .

Top Holders

Clal Biotechnology I Risk Profiles

Key Fundamentals

Clal Biotechnology Against Markets

Current Ratings

Clal Biotechnology 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Clal Biotechnology Industries Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. more
NameClal Biotechnology Industries Ltd
Chairman of the BoardAvraham FischerView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business AddressAzrieli Center
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
Phone972 3 612 1616
CurrencyILS - Israeli Shekel

Clal Biotechnology Corporate Directors

Sigalia Heifetz Director
Shmuel Rubinstein External Director
Tomer Babai Director
Check also Trending Equities. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.